Clinical Evaluation of Smoker Periodontal Subjects After Lactobacillus-reuteri Probiotics and Antibiotics Therapy
1 other identifier
interventional
66
1 country
1
Brief Summary
It is a clinical trial conducted on smokers with chronic periodontitis in which the participants are divided into two groups and one group is provided with antibiotics while the other with probiotics as an adjunct to non-surgical therapy. The participants were assessed for change in probing pocket depths, attachment loss, bleeding on probing, plaque index and gingival index after 1-month and 3-month period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Jul 2018
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 8, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 16, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 6, 2019
CompletedFirst Submitted
Initial submission to the registry
December 18, 2019
CompletedFirst Posted
Study publicly available on registry
December 24, 2019
CompletedDecember 24, 2019
December 1, 2019
9 months
December 18, 2019
December 20, 2019
Conditions
Outcome Measures
Primary Outcomes (9)
Change in Probing pocket depth
Probing pocket depth is recorded on six sites per tooth.
At baseline.
Change in Probing pocket depth
Probing pocket depth is recorded on six sites per tooth.
After 1-month.
Change in Probing pocket depth
Probing pocket depth is recorded on six sites per tooth.
After 3-months.
Change in Clinical attachment level
Clinical attachment level is recorded on six sites per tooth.
At baseline.
Change in Clinical attachment level
Clinical attachment level is recorded on six sites per tooth.
After 1-month.
Change in Clinical attachment level
Clinical attachment level is recorded on six sites per tooth.
After 3-months.
Change in Bleeding on probing
Bleeding on probing is recorded on six sites per tooth. Presence or absence of bleeding is checked.
At baseline.
Change in Bleeding on probing
Bleeding on probing is recorded on six sites per tooth. Presence or absence of bleeding is checked.
After 1-month.
Change in Bleeding on probing
Bleeding on probing is recorded on six sites per tooth. Presence or absence of bleeding is checked.
After 3-months.
Secondary Outcomes (6)
Change in Plaque index
At baseline.
Change in Plaque index
After 1-month.
Change in Plaque index
After 3-months.
Change in Gingival index
At baseline.
Change in Gingival index
After 1-month.
- +1 more secondary outcomes
Study Arms (2)
Antibiotics
ACTIVE COMPARATORThe antibiotic group is provided with amoxicillin capsules 500mg and metronidazole tablets 400mg three times a day for 7 days along with the placebo of probiotics twice daily for 30 days.
Probiotics
EXPERIMENTALThe probiotic group is provided with Lactobacillus-reuteri probiotics (2x10(8)CFU) twice daily after brushing for 30 days.
Interventions
Lactobacillus-reuteri probiotics were used as an experimental drug.
Amoxicillin capsules 500mg and metronidazole tablets 400mg antibiotics were used as an active comparator.
Eligibility Criteria
You may qualify if:
- systemically healthy males or females.
- at least 35 years of age with minimal 3 natural teeth in each quadrant excluding 3rd molar.
- previously untreated moderate to severe generalized chronic periodontitis
- were current smokers having ≥10 cigarettes /day.
You may not qualify if:
- having periodontal therapy within the past 6 months.
- have undergone antibiotics or long-term NSAIDS therapy within the past 6 months.
- have an allergy to penicillin and metronidazole.
- having either fixed or removable prosthesis.
- pregnant or nursing females.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mehwish Ghazal
Karachi, Sindh, Pakistan
Related Publications (9)
Ikram S, Hassan N, Baig S, Borges KJJ, Raffat MA, Akram Z. Effect of local probiotic (Lactobacillus reuteri) vs systemic antibiotic therapy as an adjunct to non-surgical periodontal treatment in chronic periodontitis. J Investig Clin Dent. 2019 May;10(2):e12393. doi: 10.1111/jicd.12393. Epub 2019 Jan 20.
PMID: 30663271RESULTMorales A, Carvajal P, Silva N, Hernandez M, Godoy C, Rodriguez G, Cabello R, Garcia-Sesnich J, Hoare A, Diaz PI, Gamonal J. Clinical Effects of Lactobacillus rhamnosus in Non-Surgical Treatment of Chronic Periodontitis: A Randomized Placebo-Controlled Trial With 1-Year Follow-Up. J Periodontol. 2016 Aug;87(8):944-52. doi: 10.1902/jop.2016.150665. Epub 2016 Mar 4.
PMID: 26944407RESULTTheodoro LH, Claudio MM, Nuernberg MAA, Miessi DMJ, Batista JA, Duque C, Garcia VG. Effects of Lactobacillus reuteri as an adjunct to the treatment of periodontitis in smokers: randomised clinical trial. Benef Microbes. 2019 Apr 19;10(4):375-384. doi: 10.3920/BM2018.0150. Epub 2019 Apr 1.
PMID: 30931588RESULTVicario M, Santos A, Violant D, Nart J, Giner L. Clinical changes in periodontal subjects with the probiotic Lactobacillus reuteri Prodentis: a preliminary randomized clinical trial. Acta Odontol Scand. 2013 May-Jul;71(3-4):813-9. doi: 10.3109/00016357.2012.734404. Epub 2012 Nov 26.
PMID: 23176716RESULTAssem NZ, Alves MLF, Lopes AB, Gualberto EC Junior, Garcia VG, Theodoro LH. Antibiotic therapy as an adjunct to scaling and root planing in smokers: a systematic review and meta-analysis. Braz Oral Res. 2017 Jul 3;31:e67. doi: 10.1590/1807-3107BOR-2017.vol31.0067.
PMID: 28678975RESULTGrusovin MG, Bossini S, Calza S, Cappa V, Garzetti G, Scotti E, Gherlone EF, Mensi M. Clinical efficacy of Lactobacillus reuteri-containing lozenges in the supportive therapy of generalized periodontitis stage III and IV, grade C: 1-year results of a double-blind randomized placebo-controlled pilot study. Clin Oral Investig. 2020 Jun;24(6):2015-2024. doi: 10.1007/s00784-019-03065-x. Epub 2019 Oct 16.
PMID: 31620939RESULTAlbandar JM. Adjunctive antibiotics with nonsurgical periodontal therapy improve the clinical outcome of chronic periodontitis in current smokers. J Evid Based Dent Pract. 2012 Sep;12(3 Suppl):63-6. doi: 10.1016/S1532-3382(12)70015-5.
PMID: 23253833RESULTMorales A, Gandolfo A, Bravo J, Carvajal P, Silva N, Godoy C, Garcia-Sesnich J, Hoare A, Diaz P, Gamonal J. Microbiological and clinical effects of probiotics and antibiotics on nonsurgical treatment of chronic periodontitis: a randomized placebo- controlled trial with 9-month follow-up. J Appl Oral Sci. 2018 Jan 18;26:e20170075. doi: 10.1590/1678-7757-2017-0075.
PMID: 29364340RESULTIkram S, Hassan N, Raffat MA, Mirza S, Akram Z. Systematic review and meta-analysis of double-blind, placebo-controlled, randomized clinical trials using probiotics in chronic periodontitis. J Investig Clin Dent. 2018 Aug;9(3):e12338. doi: 10.1111/jicd.12338. Epub 2018 Mar 31.
PMID: 29604177RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Shahbaz Ahmed, BDS/FCPS
Dow University of Health Sciences
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
December 18, 2019
First Posted
December 24, 2019
Study Start
July 8, 2018
Primary Completion
April 16, 2019
Study Completion
May 6, 2019
Last Updated
December 24, 2019
Record last verified: 2019-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- The data will be available after the publication of the study for 1 year.
- Access Criteria
- Contact the principal investigator through email.
The data will be available for sharing after 6-months of publication.